Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer

Protein Cell ›› 2026, Vol. 17 ›› Issue (1) : 89 -89.

PDF (143KB)
Protein Cell ›› 2026, Vol. 17 ›› Issue (1) :89 -89. DOI: 10.1093/procel/pwaf036
Correction
Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
Author information +
History +
PDF (143KB)

Cite this article

Download citation ▾
null. Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer. Protein Cell, 2026, 17(1): 89-89 DOI:10.1093/procel/pwaf036

登录浏览全文

4963

注册一个新账户 忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

© The Author(s) 2025. Published by Oxford University Press on behalf of Higher Education Press.

PDF (143KB)

44

Accesses

0

Citation

Detail
Sections
Recommended

/

〈 〉